Nitric oxide from neuronal cells plays detrimental roles in glutamate neurotoxicity and in focal brain ischemia, Nitric oxide directly damages DNA, and breaks in the DNA strands activate poly(ADP-ribose) polymerase (PARP), which brings poly(ADP-ribosyl)ation of the nuclear proteins, The ex cessive activation of PARP is thought to cause depletion of ATP and the energy failure resulting in cell death, To clarify the involvement of poly(ADP-ribosyl)ation in ischemic insult, we examined poly(ADP ribosyl)ation by immunohistochemical methods and the protective effect of 3-aminobenzamide, which is a PARP inhibitor, on focal brain ischemia using an intralu minal permanent middle cerebral artery occlusion model in rats, Poly(ADP ribosyl)ation was widely and markedly detected 2 hours after the ischemic insult in the cerebral cortex and
In cultured neurons, nitric oxide (NO) mediates glu tamate neurotoxicity, but in ischemic circumstances, NO plays both beneficial and detrimental roles, and the effect of nitric oxide synthetase (NOS) inhibitors in focal brain ischemia has been controversiaL This is mainly because NO is produced from various NOS isoforms (Iadecola et aL, 1994) , It has been shown that a specific neuronal NOS (nNOS) inhibitor, 7-nitroindazole (7-NI), is neuro protective in the rat focal brain ischemia model (Yoshida et aL, 1994) , and that nNOS knockout mice are resistant to focal brain ischemia (Huang et aL, 1994) , These data suggest that NO produced from neurons is cytotoxic in focal ischemia, The free radical NO reacts with super oxide anion and produces peroxynitrite, which is one of striatum in which infarction developed 24 hours later, The en hanced immunoreactivity of poly(ADP-ribose) gradually de creased, and 16 hours later, no immunoreacti vity was detected, Intraventricular administration of 3-aminobenzamide (1 to 30 mg/kg) 30 minutes before the ischemic insult decreased infarc tion volume in a dose-dependent manner along with the immu nohistochemical reduction of poly(ADP-ribosyl)ation, Pretreat ment with 7-nitroindazole (25 mg/kg, intraperitoneally), a se lective neuronal nitric oxide synthetase inhibitor, partially reduced poly(ADP-ribosyl)ation, These data suggest the in volvement of poly(ADP-ribosyl)ation in the development of cerebral infarction, Key Words: Poly(ADP-ribosyl)ation Poly(ADP-ribose) polymerase-3-Aminobenzamide-Nitric oxide-Focal ischemia-Rat the most powerful radicals, Peroxynitrite and NO di rectly damage DNA and enzymes involved in mitochon drial respiration (Wink et aL, 1991) , Studies indicate that one major pathway in which NO may exert toxicity is the activation of poly(ADP-ribose) polymerase (PARP) through damaging DNA, In neuronal cell cultures, NO and glutamate are able to activate PARP through dam aging DNA (Cosi et aL, 1994; Zhang et aL, 1994 Zhang et aL, , 1995 , Once activated, PARP catalyzes poly(ADP-ribosyl)ation, the transfer of ADP ribose units from NAD to nuclear proteins, The excessive activation of P ARP causes deple tion of NAD and ATP, and leads to an energy failure, Furthermore, the inhibition of P ARP reduces the neuro toxicity of NO and glutamate (Cosi et aL, 1994; Zhang et aL, 1994 Zhang et aL, , 1995 , These data indicate that the energy fail ure from excessive activation of P ARP takes part in NO and glutamate neurotoxicity,
The current study clarifies-by using an intraluminal permanent middle cerebral artery (MCA) occlusion model in rats-the immunohistochemical involvement of poly(ADP ribosyl)ation and the neuroprotective effect of 3-aminobenzamide (3-ABA), which is a PARP inhibitor, as they affect the development of cerebral infarction,
MATERIALS AND METHODS

Induction of focal brain ischemia
Male Sprague-Dawley rats (Shimizu Laboratory Supplies Co., Ltd., Kyoto, Japan) weighing 280 to 320 g were used. After overnight fasting, rats were anesthetized with 4.0% halo thane and maintained with 1.0% halothane in a gas mixture of 30% oxygen170% nitrous gas using a face mask. The rectal temperature was maintained at 37.5 ± 0.5°C during surgery with a heating lamp and a heating pad connected to a rectal thermistor. The right femoral artery was cannulated to record blood pressure and to obtain arterial blood samples. Focal brain ischemia was induced under spontaneous respiration according to a method of intraluminal MCA occlusion with slight modi fication (Longa et a!., 1989) . Briefly, the right common carotid artery, external carotid artery, and internal carotid artery were isolated through a midline cervical skin incision under a mi croscope. Approximately 18 mm of 4-0 nylon monofilament, which was blunted by coating with silicone, was advanced from the lumen of the external carotid artery into the internal carotid artery to block the origin of the right MCA. Rats were allowed to survive for the indicated period before killing. Control ani mals were operated without MCA occlusion.
Pretreatment with 3-aminobenzamide and 7-nitroindazole
To examine the effect of 3-ABA (nacalai tesque, Kyoto, Japan), a PARP inhibitor, on brain ischemia, 3-ABA (0, I, 3, 10, 30 mg/kg) was administered into the right lateral ventricle stereotactically 30 minutes before the ischemic insult under general anesthesia (described earlier). In a preliminary experi ment, a dose of I to 100 mg/kg of 3-ABA was administered intraperitoneally 30 minutes before the ischemic insult with no reduction of infarction volume. Therefore, we used intraven tricular injection of 3-ABA. The heads of rats were secured in a stereotactic frame, and a 26-gauge needle was inserted into the right lateral ventricle. Coordinates were 1.5 mm lateral, 0.8 mm posterior, and 3. 3 mm ventral from the dural surface using bregma as a landmark. Thirty microliters of each drug solution were injected over 5 minutes. The 3-ABA was dissolved in distilled water, and pH was adjusted to 7.0. To examine the involvement of NO from nNOS in the induction of poly(ADP ribosy\)ation, 7-NI (25 mg/kg) (Lancaster Co., Edinburg, U.K.) was administered intraperitoneally 30 minutes before the isch emic insult. The 7-NI was suspended in peanut oil (nakalai tesque, Kyoto, Japan).
Tissue preparation and immunohistochemistry
To clarify the temporal and spatial distribution of poly(ADP ribosyl)ation after focal brain ischemia, rats were transcardially perfused with 4% paraformaldehyde in phosphate-buffered sa line (pH 7.4) at 1, 2, 4, 8, 16, and 24 hours after the induction of ischemia (n = 3 at each time point). Control animals (n = 3) were killed 8 hours after operation. To examine the effect of 3-ABA (0, 1,3, 10,30 mg/kg) and 7-NI (25 mg/kg) on poly (ADP-ribosyl)ation after ischemia, rats (n = 3 for each dose) were perfused as described earlier at 2 hours after ischemia. The brains were rapidly removed and cryoprotected in 25% sucrose in phosphate-buffered saline overnight at 4 0c. Frozen coronal sections (50-fLm thickness) were prepared. After quenching endogenous peroxidase in 2% H202 in 60% metha nol and blocking with 5% goat serum, sections were incubated overnight at 4°C with polyclonal antibody against poly(ADP ribose) (Ikai et aI., 1980) . This antibody was a polyclonal an tibody raised in rabbits against purified poly(ADP-ribose) (av erage chain length, 24); it was most reactive with polymers having the chain length of about 25 ADP-ribose units and J Cereb Blood Flow Metab. Vol. 18. No.9. 1998 weakly reactive with short oligomers. The specificity was con firmed by the disappearance of the immunostaining by preab sorption of the antiserum with purified poly(ADP-ribose) or by pretreatment of tissue sections with poly(ADP-ribose) degrading enzymes. The sections were washed with phosphate buffered saline, and then incubated with biotinylated anti-rabbit IgG antibody at 1:200 dilution for 2 hours and with an avidin biotin complex (ABC kit from Vector) for 60 minutes. Peroxi dase was demonstrated with a DAB substrate kit (Funakoshi, Tokyo, Japan). Negative control sections received identical treatment except for the primary antibody. We also used the commercially available polyclonal anti-poly(ADP-ribose) anti body prepared from guinea pig serum (Trevigen, Gaithersburg, MD, U.S.A.) to check interantibody differences in immunore activity. For evaluation of morphologic change, contiguous sections were stained with cresyl violet.
Measurement of infarction volume
To examine the effect of intraventricular administration of 3-ABA 30 minutes before the ischemia on the development of cerebral infarction, rats were killed 24 hours later after isch emic insult for 2, 3,5-triphenyltetrazolium chloride (nacalai tesque) staining (Bederson et aI., 1986) to measure infarction volume. Twenty-seven rats were used (n = 7, 4, 6, 6, 4 for vehicle and doses of 1, 3, 10, and 30 mg/kg, respectively). Rats were decapitated, the brains were removed immediately, and seven coronal slices 2, 4, 6, 8, 10, 12, and 14 mm distal from the frontal pole were dissected using a brain slicer. Infarction areas were calculated for each coronal slice by NIH Image (ver. 1.56), and infarction volumes were determined by numeric in tegration of infarction areas. Data were presented as mean ± SD and statistically analyzed using analysis of variance followed by post hoc Bonferroni test using Stat View II (Abacus Con cepta, Berkeley, CA, U.S.A.), and when P is less than 0.05, differences were considered significant.
RESULTS
Immunohistochemistry of poly(ADP-ribose)
Two hours after the intraluminal right MeA occlusion, neuronal damage was detected only in the medial part of Figs. 2A, D , G, and J were taken at the site of square 1. Figs. 28, E, H, and K, and C, F, I, and L were taken at the site of squares 2 and 3, respectively. No immunoreactive cells were observed 0 hours after ischemic insult (A-C). Poly(ADP ribosyl)ation was found throughout the ischemic area 2 hours after ischemic insult. Immunoreactivity was found mainly in nuclei (D-F).
Eight hours after ischemic insult, the positive nuclei appeared larger and rounder (G-I). No positive cells were found 24 hours after ischemic insult (J-L). All of the photographs were taken under the same magnification. The bar in Fig. 2L indicates 20 IJm.
right striatum in cresyl violet staining. Neuronal damages gradually expanded thereafter, and 24 hours later a dam aged area expanded to most of the right striatum and right frontoparietal cortex (Fig. 1) .
We used two polyclonal antibodies, and temporal and spatial distribution of poly(ADP-ribosyl)ation was essen-tially the same. The main difference between the immu noreactivities in two antibodies was the intracellular dis tribution. The antibody from by Ikai and others produced strong immunoreactivity, mainly in the nuclei with faint staining in the cytoplasm (Figs. 2 and 3) , but the anti body from Trevigen produced diffuse immunoreactivity,
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T. TOKIME ET AL. immunohistochemical study at the area of square 1 (indicated in Fig. 1 ) 2 hours after ischemic insult in animals that received in traventricular injection of vehicle (A), intraventricular injection of 10 mg/kg of 3-aminobenzamide (3-ABA) (8), and intraperitoneal injection of 25 mg/kg of 7-nitroindazole (7-NI) (C) 30 minutes before ischemic insult. In animals that received vehicles, poly (ADP-ribose) immunoreactivity was the same as in animals that received only ischemic insult. Intraventricular administration of 10 mg/kg of 3-ABA markedly reduced the immunoreactivity (8). In traperitoneal injection of 25 mg/kg of 7-NI moderately reduced the immunoreactivity (C). The bar in C indicates 10 �m.
both in the nuclei and cytoplasm (see Sugino et aI, 1997 ). In the current study, we demonstrated the results ob tained using the former, since the antibody from Trevi gen produced higher background than the polyclonal an tibody by Ikai and colleagues.
In the control group and 0 hours after ischemic insult, no poly(ADP-ribosyl)ation was detected in the striatum J Cereb Blood Flow Metab. Vol. 18. No.9, 1998 or frontoparietal cortex (Figs. 1 and 2A through C). Faint poly(ADP-ribose) immunoreactivity was detected only in neurons of the piriform cortex and cingulate gyrus. One hour after ischemic insult, poly(ADP-ribosyl)ation was weakly detected in the medial and lateral striatum and in the frontoparietal cortex (data not shown). Two hours after ischemic insult, poly(ADP-ribosyl)ation peaked in the lateral striatum and throughout the fronto parietal cortex (Fig. 2D through F) . We confirmed that the positive cells were mostly neurons by using morpho logic study and a double staining method (data not shown). Among intracellular organelles, nuclei were stained prominently with occasional faint staining in the cytoplasm (Fig. 3A) . In the medial part of striatum, in which neurodegeneration was severe, the staining was less dense. Ischemic penumbra in the cortex, which is indicated as square 2 in Fig. 1 , showed moderate immu noreactivity. The piriform cortex, in which neuronal de generation could not be found 24 hours later in this model, also showed moderate immunoreactivity. Four hours after ischemic insult, the number of positive cells gradually decreased. Eight hours after ischemic insult ( Fig. 2G through I) , the positive cells decreased rapidly in the striatum, and the positive cells were prominent only in the fifth layer of the cortex, although the piriform cortex was stained moderately. At this time, the staining showed a larger and rounder shape, probably because of degeneration of nuclei (Fig. 2G) . Sixteen hours and 24 hours after intraluminal MCA occlusion, the immunore activity of poly(ADP-ribose) almost completely disap peared ( Figs. 1 and 2J through L) . Contralateral hemi sphere showed no poly(ADP-ribose) immunoreactivity during the ischemic period, except faint staining in the piriform cortex and cingulate gyrus. Negative control without primary antibody did not show poly(ADP ribose) immunoreactivity, either.
The effect of 3-aminobenzamide and 7-nitroindazole on poly(ADP-ribosyl)ation Intraventricular administration of 3-ABA (0, I, 3, 10, 30 mg/kg) 30 minutes before the ischemic insult reduced poly(ADP-ribose) immunoreactivity 2 hours after isch emia in a dose-dependent manner, and the maximum reduction of the poly(ADP-ribose) immunoreactivity was obtained with a dose of 10 mg/kg (Fig. 3A and B) . The reduction of immunoreactivity was more prominent in the cortex than in the striatum (data not shown). In traperitoneal administration of 25 mg/kg of 7-NI moder ately reduced poly(ADP-ribose) immunoreactivity 2 hours after ischemia (Fig. 3C) , but less effectively than 3-ABA. 6/6, and 4/4 for vehicle and doses of 1, 3, 10, and 30 mg/kg of 3-ABA, respectively. Intraventricular adminis tration of 3-ABA (0, 1, 3, 10, and 30 mg/kg) 30 minutes before the ischemic insult significantly reduced infarc tion volume 24 hours after the ischemia in a dose dependent manner, and the maximum effect was ob-tained at a dose of 10 mg/kg ( Figs. 4 and 5) . The reduc tion of infarction volume was more prominent in the cortex than in the striatum. Systemic blood pressure, ar terial gas analysis (pH, Paz, Pcoz), hematocrit, and blood glucose were not significantly different between groups 5 minutes before the ischemia (Table 1) .
DISCUSSION
Poly(ADP-ribose) polymerase is activated by DNA breakage, resulting in the addition of up to 100 ADP ribose groups to acceptors such as histone and P ARP itself. After limited damages of DNA, poly(ADP ribosyl)ation plays a critical role in DNA repair (de Mar cia and de Marcia, 1994) . However, when massive dam age of DNA occurs, the associated extensive activation of PARP is thought to lead to depletion of NAD, which is the donor of the ADP-ribose group. Also, ATP is depleted in efforts to resynthesize NAD, resulting in cell death. Zhang and associates (1994) showed that NO ac tivated PARP and that the inhibition of PARP rescued from NO-and N-methyl-D-aspartate-mediated neurotox icity in a cortical culture. Cosi and colleagues (1994) showed by immunohistochemical study that glutamate induced poly(ADP-ribosyl)ation in cerebellar granule cells. They also showed that inhibitors of PARP reduced glutamate neurotoxicity. Also, in other cell lines, the in hibition of PARP has been shown to induce protective /' effects on cytotoxicity by several stimuli, including NO (Burkart et aI., 1995; Heller et aI., 1995; Kuo et a1., 1996; Nosseri et aI., 1992; Radons et aI., 1994; Zingarelli et aI., 1996) . These results strongly suggest the involvement of poly(ADP-ribosyl)ation in the process of cell death. An other mechanism of cell death by poly(ADP-ribosyl)ation MABP (mean arterial blood pressure), arterial blood gas (pH, Po" Peo2), Hct (hematocrit), and blood glucose were measured 5 minutes before middle cerebral artery occlusion. Data are presented as mean ± SD. other than energy failure was proposed by Nosseri and coworkers (1992) . They speculated that poly(ADP ribosyl)ation may represent a quantity of DNA damages, and some intracellular signal transduction mechanisms for cell death may exist after poly(ADP-ribosyl)ation.
The current study showed that poly(ADP-ribosyl)ation was detected 1 hour and peaked 2 hours after focal brain ischemia model, where infarction developed several hours later. These findings indicate that P ARP is acti vated in vivo in the early phase of the development of infarction. Because PARP recognizes the site of DNA single-strand breaks but not the site of double-strand breaks, poly(ADP-ribosyl)ation in the focal cerebral ischemia may reflect early damages of single-strand DNA in ischemic regions.
When we used the antibody by Ikai and colleagues, poly(ADP-ribose) immunoreactivity was mainly located in the nucleus of neurons, where DNA damages and repairs should occur. A few neurons in severe ischemic regions showed weak poly(ADP-ribose) immunoreactiv ity in the cytoplasm, along with strong poly(ADP-ribose) immunoreactivity in the nucleus. The commercially available polyclonal antibody (Trevigen) produced dif fuse, positive staining both in the nucleus and cytoplasm. Further study is needed to clarify whether activation of PARP and poly(ADP-ribosyl)ation will occur in the cy toplasm, as well as the locus of poly(ADP-ribosyl)ation in the cytoplasm.
The current study also demonstrates that 3-ABA, which is a PARP inhibitor, reduced mortality rate and also reduced infarction volume dose dependently, along with the reduction of poly(ADP-ribosyl)ation in perma nent MCA occlusion model in rats. The maximum re duction in infarction volume was obtained by 40% at a dose of 10 mg/kg. In this dosage, poly(ADP ribosyl)ation did not disappear completely. During the preparation of this manuscript, Eliasson et aI. (1997) showed that genetic disruption of P ARP provides pro found protection against glutamate-NO-mediated isch emic insults in vitro and major decreases in infarction volume after reversible MCA occlusion. They have dem onstrated 80% reduction in infarction volume in P ARP knockout mice. The differences in the neuroprotective J Cereb Blood Flow Metab, Vol. 18, No.9, 1998 effect of P ARP inhibition in these two experiments may reflect the difference in the ischemia model (permanent versus transient) and the drug delivery and bioavailabil ity.
It has been recently shown that NO and glutamate are able to activate P ARP through damaging DNA in neu ronal cell culture (Cosi et aI., 1994; Zhang et aI., 1994 Zhang et aI., , 1995 . We have shown in the current study that focal brain ischemia induced poly(ADP-ribosyl)ation, and that 7-NI, a specific nNOS inhibitor, reduced poly(ADP ribosyl)ation in vivo. Because 7-NI could not block poly (ADP-ribosyl)ation completely, PARP may be activated through NO, as well as other stimuli, during focal brain ischemia.
The current study demonstrates the strong involve ment of poly(ADP-ribosyl)ation in the development of cerebral infarction in focal ischemia model, and implies a new therapeutic modality for ischemic brain injury through the inhibition of poly(ADP-ribosyl)ation.
